Results 61 to 70 of about 59,640 (292)

Primary open angle glaucoma and hypothyroidism

open access: yesClinical Optometry, 2010
George Kitsos1, Chrisavgi Pappa1, Agathoklis Tsatsoulis21Department of Ophthalmology, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece; 2Endocrinology Clinic, Department of Internal Medicine, Medical School ...
George Kitsos   +2 more
doaj  

Pharmacogenetics of ophthalmic topical β-blockers [PDF]

open access: yes, 2008
Glaucoma is the second leading cause of blindness worldwide. The primary glaucoma risk factor is elevated intraocular pressure. Topical β-blockers are affordable and widely used to lower intraocular pressure.
McCarty, Catherine A.   +4 more
core   +1 more source

Primary open-angle glaucoma genes [PDF]

open access: yesEye, 2011
A substantial fraction of glaucoma has a genetic basis. About 5% of primary open angle glaucoma (POAG) is currently attributed to single-gene or Mendelian forms of glaucoma (ie glaucoma caused by mutations in myocilin or optineurin). Mutations in these genes have a high likelihood of leading to glaucoma and are rarely seen in normal subjects.
openaire   +2 more sources

Advancing Extracellular Vesicle Research: A Review of Systems Biology and Multiomics Perspectives

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are membrane‐bound vesicles secreted by various cell types into the extracellular space and play a role in intercellular communication. Their molecular cargo varies depending on the cell of origin and its functional state.
Gloria Kemunto   +2 more
wiley   +1 more source

Stimuli‐responsive systems: A focus on controlled drug delivery for posterior segment ocular disease

open access: yesResponsive Materials, EarlyView.
This review highlights recent advances in stimuli‐responsive drug delivery for posterior segment diseases, focusing on mechanisms and potential. It also explores mechanically interlocked molecules and bioorthogonal reactions as novel approaches. Challenges and future perspectives are discussed, aiming to bridge the gap between research and clinical ...
Chengzhi Zhang   +11 more
wiley   +1 more source

A study of primary open angle glaucoma in Diabetic patients [PDF]

open access: yesPerspectives In Medical Research, 2018
Introduction: Primary open angle glaucoma is the commonest form of glaucoma accounting for atleast half of all the glaucomas. Intra Ocular Pressure is a definite and important risk factor for developing glaucomatous damage. Open-angle glaucoma is an
Shri Krishna Ingle1 , Yasam Soumya2 , Jaganmohan Rao3 , S. Kapil4
doaj  

Success Rate of Trabeculectomy in Primary Glaucoma at Cicendo Eye Hospital on January–December 2013

open access: yesAlthea Medical Journal, 2016
Background: Trabeculectomy is a surgical therapy for glaucoma to preserve visual function by lowering intraocular pressure (IOP). In some studies, the success of trabeculectomy in lowering IOP is greater than medication. Success is defined by IOP
Erva Monica Saputro   +2 more
doaj   +1 more source

Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Remimazolam, a new ultra‐short‐acting benzodiazepine, is a safe and effective option for procedural sedation. Nevertheless, to date, no study has directly compared remimazolam and midazolam in diagnostic upper gastrointestinal endoscopy. This study aimed to evaluate the efficacy and safety of remimazolam compared with those
Yehyun Park   +7 more
wiley   +1 more source

A Randomised Open Label Comparative Clinical Trial on the Efficacy of Latanoprost and Timolol in Primary Open Angle Glaucoma [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Timolol, a beta blocker, is the most commonly prescribed first line therapy in the treatment of primary open angle glaucoma. Latanoprost, a prostaglandin analogue, is a novel drug in glaucoma therapy.
Sharadashri Rao, P.V. Narayanan
doaj   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy